MGC ain't pretending anything! They're the first ASX listed pot coy with a million dollar sales contract with others in the pipeline and are about to harvest a test crop. That said, AusCann's board looks mighty and, in agreement with Spec, Canopy's involvement here is exciting. The two are my picks from the bunch.
I'm a bit confused about the Zelda connection though, as (in my understanding) ZLD claim to have exclusivity on all of Aunt Z's IP from the US. I know they could easily trade this exclusivity for a 5% royalty from AusCann, but I haven't heard anything to that effect. The prospectus (page 80) seems to suggest that AusCann has exactly the arrangement with Aunt Zelda (US parent) that Zelda Therapeutics (Aust subsidiary) boasts.
Can you shed any light on the Zelda deal?
TWH Price at posting:
1.2¢ Sentiment: Hold Disclosure: Held